Pyr41

Pyr41__E1 UAE inhibitor SMND-310

Product Name Pyr41
Description

E1 UAE inhibitor

Purity >98%
CAS No. 418805-02-4
Molecular Formula C17H13N3O7
Molecular Weight 371.3
Storage Temperature -20ºC
Shipping Temperature Shipped Ambient
Product Type Inhibitor
Solubility Soluble in 25 mg/ml DMSO
Source Synthetic
Appearance Brown Powder
SMILES CCOC(=O)C1=CC=C(C=C1)N2C(=O)/C(=CC3=CC=C(O3)N+(=O)O-)/C(=O)N2
InChI InChI=1S/C17H13N3O7/c1-2-26-17(23)10-3-5-11(6-4-10)19-16(22)13(15(21)18-19)9-12-7-8-14(27-12)20(24)25/h3-9H,2H2,1H3,(H,18,21)/b13-9-
InChIKey ARGIPZKQJGFSGQ-LCYFTJDESA-N
Safety Phrases Classification: Caution: Substance not yet fully tested.
Safety Phrases:
S22 – Do not breathe dust
S36/37/39 – Wear suitable protective clothing, gloves and eye/face protection
S24/25- Avoid contact with skin and eyes
Hazard Statements:
H302 – May be harmful if swallowed
H317 – May cause an allergic skin reaction
Precautionary Statements:
P280 – Wear protective gloves
Cite This Product Pyr41 (StressMarq Biosciences Inc., Victoria BC CANADA, Catalog # SIH-330)
Alternative Names Ethyl 4-{(4Z)-4-(5-nitro-2-furyl)methylene-3,5-dioxo-1-pyrazolidinyl}benzoate, PYR-41, 44-(5-Nitro-furan-2-ylmethylene)-3,5-dioxo-pyrazolidin-1-yl-benzoic acid ethyl ester
Research Areas Cancer, Apoptosis
PubChem ID 5335621
Scientific Background Inhibits ubiquitin activating enzyme E1 (>60% inhibition at 10 µM) with little or no activity against E2 or E3. Cell permeable.
References 1. Yang Y., et al. (2007) Cancer Res. 67: 9472.
2. Mi L., et al. (2009) J. Biol. Chem. 284: 17039.